Flavonoids have been tested in AD models and seem to be able to reduce AD severity by modulating the production of microglia pro-inflammatory cytokines (TNF-α and IL-1β) or by reducing their Aβ-induced cytokine production [3]. This evidence concerns the gene IL1B and Alzheimer disease.